Litcius/Paper detail

Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons

Tuire Saloranta, Frida Gyllenberg, Anna But, Mika Gissler, Merja K. Laine, Oskari Heikinheimo

2020American Journal of Obstetrics and Gynecology27 citationsDOIOpen Access PDF

Topics & Concepts

MedicineDiscontinuationLong-acting reversible contraceptionObstetricsFamily planningPopulationInternal medicineEnvironmental healthResearch methodologyReproductive Health and ContraceptionGlobal Maternal and Child HealthPregnancy and Medication Impact
Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons | Litcius